UNIONFILL with Lidocaine — Double J Holdings HCCL™ Technology — 1.0ml
- Double J Holdings HCCL™ Technology — 24 mg/mL HA
- 3 mg/mL lidocaine for enhanced comfort
- BDDE not detected, endotoxin <0.5 EU
- For licensed professionals only
| 1 – 2 boxes | $23.50 / box |
| 3 – 9 boxes | $22.33 / box |
| 10 – 19 boxes | $21.15 / box |
| 20 – 29 boxes | $20.45 / box |
| 30+ boxes | Contact for quote |
What Is UNIONFILL with Lidocaine — Double J Holdings HCCL™ Technology — 1.0ml?
**UNIONFILL** is a three-variant Korean HA dermal filler series manufactured by Double J Holdings (Seoul, South Korea), utilizing proprietary HCCL™ (Homogeneous HA Crosslinking) technology to deliver 24 mg/mL cross-linked hyaluronic acid with 3 mg/mL lidocaine, with lab-verified BDDE residue not detected and endotoxin levels below 0.5 EU for professional facial contouring and volumization.
UNIONFILL features Double J Holdings' innovative HCCL™ technology that creates a uniform cross-linked HA network rather than patchy biphasic structures found in legacy fillers. The homogeneous matrix maintains viscosity over time and resists premature degradation, supporting consistent in-tissue performance. With third-party lab testing confirming BDDE residue below detection limits and endotoxin levels below 0.5 EU, UNIONFILL offers exceptional purity for aesthetic practitioners. Three variants (Soft, Deep, Hard) at a uniform 24 mg/mL HA concentration cover the full treatment spectrum from upper dermis fine lines to deep subcutaneous volumization.
Specifications
| Product name | UNIONFILL with Lidocaine — HCCL™ Technology |
|---|---|
| Active ingredient | Cross-linked HA 24 mg/mL + Lidocaine 3 mg/mL |
| Volume | 1 × 1.0ml pre-filled syringe |
| BDDE residue | Not detected (spec: ≤2.0 ppm) |
| Endotoxin | <0.5 EU/g |
| pH | 6.9 |
| Gel structure | Homogeneous matrix (HCCL) |
| HA Source | Bacterial fermentation, non-animal origin |
| Application | Upper dermis to subcutaneous per variant |
| Treatment areas | Fine lines, crow's feet, NLF, marionettes, cheeks, lips, chin, structural augmentation |
| Origin | South Korea (Double J Holdings, Seoul) |
| Certification | CE |
| Storage | 2–25°C, do not freeze, protect from direct sunlight |
| Shelf life | 24 months unopened |
Key Benefits
- HCCL homogeneous matrix maintains viscosity over time and resists premature degradation
- Third-party lab verified BDDE residue not detected for exceptional safety
- Endotoxin levels below 0.5 EU minimize inflammatory response risk
- Three variants (Soft/Deep/Hard) cover every dermal depth from upper dermis to subcutaneous
- 24 mg/mL HA concentration with uniform cross-linking ensures consistent clinical outcomes
Suggested Treatment Protocol
Treatment protocol varies by variant. UNIONFILL Soft is injected into the upper dermis using a 30G needle for fine lines, crow's feet, and superficial smoothing. UNIONFILL Deep targets the mid-dermis for nasolabial folds, marionette lines, and cheek contour. UNIONFILL Hard is placed in the deep dermis or subcutaneous plane for lip volume, vermillion border definition, and structural augmentation. A full treatment plan of 1–3 sessions with 4–8 week intervals is recommended. The exact injection depth, volume, and treatment schedule should be determined by the treating practitioner based on individual patient anatomy and aesthetic goals.
Perfect for our medical spa. We go through about 30-40 units a month and this has been consistently in stock. The ordering process was smooth too.
Reliable supplier, consistent quality. We've been using this for a few months now and results are solid.
The 1.0ml syringe format is convenient for our clinic workflow. Less waste compared to the 1.5ml syringes we used to buy.
Been sourcing dermal fillers for 4 years and this brand sits comfortably in our top 3. The cross-linking technology makes a real difference in longevity.
Please log in to leave a review.